VIOLET is a phase I/II trial of video-assisted thoracoscopic surgery (VATS) lobectomy versus the conventional open procedure in patients with early-stage lung cancer. The primary outcome is patient-reported physical function at 5 weeks after surgery, which the researchers hypothesize will be better with the minimal access procedure than with open lobectomy.
Data from the study indicate that Video-assisted thoracic surgery (VATS) lobectomy is associated with less pain, fewer in-hospital complications, and shorter hospital stays compared with open lobectomy for early-stage lung cancer.
The primary results were presented at WCLC 2019:
Title: In hospital clinical efficacy, safety and oncologic outcomes from VIOLET: A UK multi-centre RCT of VATS versus open lobectomy for lung cancer
Presenter: Eric Lim, Royal Brompton Hospital, London, UK
Monday, September 9: 08:55–09:05 (Abstract PL02.06)